Literature DB >> 8345058

Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion.

P J Blankestijn1, F H Derkx, J C Birkenhäger, S W Lamberts, P Mulder, L Verschoor, M A Schalekamp, R F Weber.   

Abstract

Enhanced GH secretion and hyperglycemia are suggested to play a role in the pathogenesis of glomerular hyperfiltration in insulin dependent diabetes mellitus. In this study we measured the GH response to GHRH (1 microgram/kg body weight), metabolic control, and renal function in 44 patients in order to explore a possible association between these parameters. Hyperfiltration [glomerular filtration rate (GFR) > 130 ml/min/1.73 m2] was present in 21 patients and normofiltration in 23. The duration of diabetes, plasma concentrations of renin, catecholamines, insulin-like growth factor-1 and blood glucose during renal function measurements were not different. GH response was significantly higher in patients with hyperfiltration. There was a positive relation between GH response and GFR (r = 0.51, P < 0.001) and effective renal plasma flow (r = 0.39, P < 0.01). GFR was correlated with insulin dose (r = 0.48, P < 0.001). There was no difference in glycosylated hemoglobin between the two groups. Patients with hyperfiltration used more insulin, had more frequent blood glucose values below the threshold level for activation of GH secretion, and had greater glycemic excursions than patients with normofiltration. The results suggest that GH hypersecretion and glomerular hyperfiltration are related and they support the possibility of a linkage between GH hypersecretion and glucose variability.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345058     DOI: 10.1210/jcem.77.2.8345058

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy.

Authors:  P Anil Kumar; Kateryna Kotlyarevska; Prapai Dejkhmaron; Gaddameedi R Reddy; Chunxia Lu; Mahaveer S Bhojani; Ram K Menon
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

2.  Glomerular and tubular function in glycogen storage disease.

Authors:  P J Lee; R N Dalton; V Shah; P C Hindmarsh; J V Leonard
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

Review 3.  The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.

Authors:  P Anil Kumar; Frank C Brosius; Ram K Menon
Journal:  Curr Diabetes Rev       Date:  2011-01

4.  Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation.

Authors:  Daniel Landau; Renanah Eshet; Ariel Troib; Yotam Gurman; Yu Chen; Ralph Rabkin; Yael Segev
Journal:  Endocrine       Date:  2009-04-23       Impact factor: 3.633

5.  Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes.

Authors:  David Z I Cherney; Etienne B Sochett
Journal:  Diabetes Care       Date:  2011-06-02       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.